Chronic HBV Monitoring |
|
Variable |
Odds Ratio (95% CI) |
*P-Value |
|
Patient age (per decade) |
0.99 (0.98–1.00) |
0.026 |
|
Patient male gender |
1.08 (0.92–1.28) |
0.358 |
|
Patient race (vs. Caucasian) |
|
|
Asian |
4.18 (2.40–7.27) |
<0.001 |
Black |
1.46 (0.74–2.85) |
0.273 |
Latino |
2.13 (0.75–6.04) |
0.156 |
Other |
3.88 (1.59–7.80) |
0.003 |
|
Patient insured |
0.86 (0.69–1.07) |
0.177 |
|
Provider age (per decade) |
0.87 (0.60–1.27) |
0.480 |
|
Provider male gender |
0.99 (0.98–1.00) |
0.518 |
|
Asian provider race (vs. non-Asian) |
1.00 (0.99–1.01) |
0.638 |
|
Clinic practice comprised of > 25% Asian patients |
1.00 (0.99–1.00) |
0.444 |
|
Provider knowledge score |
1.06 (0.79–1.40) |
0.712 |
|
Provider attitude score |
0.99 (0.78–1.27) |
0.965 |
|
Provider barrier score |
1.06 (0.78–1.43) |
0.722 |
|
Provider familiarity with AASLD HBV guidelines |
1.02 (1.00–1.03) |
0.012 |
|
HCC Surveillance |
|
Variable |
Odds Ratio (95% CI) |
*P-Value |
|
Patient male gender |
0.94 (0.74–1.19) |
0.616 |
|
Patient insured |
1.32 (0.74–2.36) |
0.353 |
|
Provider age (per decade) |
0.18 (0.07–0.45) |
<0.001 |
|
Provider male gender |
0.99 (0.98–1.04) |
0.867 |
|
Asian provider race (vs. non-Asian) |
1.02 (1.01–1.03) |
<0.001 |
|
Clinic practice comprised of >25% Asian patients |
0.97 (0.95–0.99) |
0.006 |
|
Provider knowledge score |
1.99 (1.14–3.48) |
0.016 |
|
Provider attitude score |
1.48 (1.08–2.03) |
0.014 |
|
Provider barrier score |
0.45 (0.24–0.85) |
0.013 |
|
Provider familiarity with AASLD HBV guidelines |
0.99 (0.97–1.00) |
0.095 |